Skip to content

Augmentation of Neuronal Network Plasticity in Schizophrenia

Augmentation of Neuronal Network Plasticity in Schizophrenia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03522220
Acronym
SCZ
Enrollment
150
Registered
2018-05-11
Start date
2016-09-01
Completion date
2019-12-31
Last updated
2018-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Schizophrenia

Brief summary

Current pathophysiological models of schizophrenia focus on disconnectivity of distributed neuronal systems to explain the multitude of psychic symptoms. However, therapeutic strategies targeting this specific pathobiology are lacking. Our recent work provides strong evidence that complex video-game training interventions facilitate fronto-hippocampal structural and functional connectivity within 2 months in healthy subjects. The planned project transfers this knowledge into a training study in schizophrenic patients to counteract disease-related disconnectivity. Underlying mechanisms and behavioral effects are extensively parametrized by resting state functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), spectroscopy and clinical short- and long-term outcome.

Interventions

BEHAVIORAL3D navigation video game intervention

Participants intensively train with a video game (Super Mario DS)

BEHAVIORALvideo game intervention without 3D navigation

Participants train with a video game (Super Mario Bros)

BEHAVIORALNo 3D navigation

Participants read on a kindle device (control group)

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* clinically stabilized * at least one schizophrenic episode in their lives * International Classification of Diseases 10 (ICD-10) F20.x (and F25)

Exclusion criteria

* clinically relevant anemia * MRI contraindication * earlier electroconvulsive shock treatment * significant somatic or neurological disease * significant alcohol or substance abuse in the year before * more than 1h video games per day more than 6 months before study start * simultaneous major psychiatric disease (if symptomatic in the foreground)

Design outcomes

Primary

MeasureTime frameDescription
T1 - MRI2 months (= training time and 2 months after training end)The investigators look for structural volume changes in T1 images (MRI) specifically in the hippocampus and prefrontal areas due to training
Cognition - Spatial Orientation2 months (= training time and 2 months after training end)The investigators look for changes in cognition specifically regarding spatial orientation (MATRICS, computer tests measuring spatial orientation with and without external cue) due to training.
Positive & Negative Symptoms in patients2 months (= training time and 2 months after training end)The investigators look for changes in positive and negative symptoms (PANSS) due to training.

Secondary

MeasureTime frameDescription
Resting State fMRI2 months (= training time and 2 months after training end)The investigators look for blood oxygen level dependency (BOLD) changes in resting state fMRI specifically in the Hippocampus and Prefrontal Areas due to the training
Biomarkers (BDNF & interleukin 1 & 6)2 month (= training time and 2 month after training end)The investigators look for plasticity induced changes in biomarkers (interleukin1 and 6 and BDNF \[brain-derived neurotrophic factor\]) due to training
Spectroscopy - glutamate2 month (= training time and 2 month after training end)The investigators look for glutamate concentration changes in the hippocampus due to the training
Diffusion Tensor Imaging (DTI)2 month (= training time and 2 month after training end)The investigators look for structural connectivity changes in DTI images due to the training

Countries

Germany

Contacts

Primary ContactMaxi Becker, MSc
max.becker@uke.de
Backup ContactSimone Kühn, Prof
s.kuehn@uke.de

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026